Abstract:Computational inference of novel therapeutic values for existing drugs, i.e., drug repositioning, offers the great prospect for faster and low-risk drug development. Previous researches have indicated that chemical structures, target proteins, and side-effects could provide rich information in drug similarity assessment and further disease similarity. However, each single data source is important in its own way and data integration holds the great promise to reposition drug more accurately. Here, we propose a new method for drug repositioning, PreDR (Predict Drug Repositioning), to integrate molecular structure, molecular activity, and phenotype data. Specifically, we characterize drug by profiling in chemical structure, target protein, and side-effects space, and define a kernel function to correlate drugs with diseases. Then we train a support vector machine (SVM) to computationally predict novel drug-disease interactions. PreDR is validated on a well-established drug-disease network with 1,933 interactions among 593 drugs and 313 diseases. By cross-validation, we find that chemical structure, drug target, and side-effects information are all predictive for drug-disease relationships. More experimentally observed drug-disease interactions can be revealed by integrating these three data sources. Comparison with existing methods demonstrates that PreDR is competitive both in accuracy and coverage. Follow-up database search and pathway analysis indicate that our new predictions are worthy of further experimental validation. Particularly several novel predictions are supported by clinical trials databases and this shows the significant prospects of PreDR in future drug treatment. In conclusion, our new method, PreDR, can serve as a useful tool in drug discovery to efficiently identify novel drug-disease interactions. In addition, our heterogeneous data integration framework can be applied to other problems.

deepDR: a network-based deep learning approach to in silico drug repositioning

Deep learning identifies explainable reasoning paths of mechanism of action for drug repurposing from multilayer biological network

Drug Repositioning Method Based on Deep Neural Network

DR3E-Net: Drug Repurposing Network Framework Based on Deep Embedding, Differentially Expressed Genes, and Drug Side Effects

Drug repositioning based on the heterogeneous information fusion graph convolutional network

A Fused Deep Learning Approach to Transform Novel Drug Repositioning

AI-DrugNet: A network-based deep learning model for drug repurposing and combination therapy in neurological disorders

DrugRepPT: a Deep Pre-Training and Fine-Tuning Framework for Drug Repositioning Based on Drug's Expression Perturbation and Treatment Effectiveness.

DRONet: effectiveness-driven drug repositioning framework using network embedding and ranking learning

Drug Repositioning Based on Deep Sparse Autoencoder and Drug-Disease Similarity

A Drug Repositioning Algorithm Based on a Deep Autoencoder and Adaptive Fusion

Drug repositioning with adaptive graph convolutional networks

DeepDRK: a deep learning framework for drug repurposing through kernel-based multi-omics integration

Drug Repositioning By Kernel-Based Integration Of Molecular Structure, Molecular Activity, And Phenotype Data

Drug repositioning for Alzheimer's disease with transfer learning

Target identification among known drugs by deep learning from heterogeneous networks

Network-Based Approaches for Drug Repositioning.

DeepDrug: An Expert-led Domain-specific AI-Driven Drug-Repurposing Mechanism for Selecting the Lead Combination of Drugs for Alzheimer's Disease

Drug Repositioning by Collaborative Learning Based on Graph Convolutional Inductive Network

Machine Learning and Deep Learning Strategies in Drug Repositioning

A weighted bilinear neural collaborative filtering approach for drug repositioning